open access

Vol 79, No 10 (2021)
Editorial
Published online: 2021-10-05
Get Citation

Gentamicin-collagen sponge and prevention of cardiac implantable electronic device infections: bargain basement or penthouse suite?

Larry M Baddour1, Zerelda Esquer Garrigos12
DOI: 10.33963/KP.a2021.0122
·
Pubmed: 34611880
·
Kardiol Pol 2021;79(10):1055-1057.
Affiliations
  1. Division of Infectious Diseases, Department of Medicine and Cardiovascular Disease, Mayo Clinic College of Medicine and Science, Mayo Clinic, Rochester, Minnesota, United States of America
  2. Division of Infectious Diseases, Department of Medicine, University of Mississippi Medical Center, Jackson, Mississippi, United States of America

open access

Vol 79, No 10 (2021)
Editorial
Published online: 2021-10-05

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

Gentamicin-collagen sponge and prevention of cardiac implantable electronic device infections: bargain basement or penthouse suite?

Journal

Kardiologia Polska (Polish Heart Journal)

Issue

Vol 79, No 10 (2021)

Article type

Editorial

Pages

1055-1057

Published online

2021-10-05

Page views

982

Article views/downloads

303

DOI

10.33963/KP.a2021.0122

Pubmed

34611880

Bibliographic record

Kardiol Pol 2021;79(10):1055-1057.

Authors

Larry M Baddour
Zerelda Esquer Garrigos

References (14)
  1. Baddour L, Epstein A, Erickson C, et al. Update on cardiovascular implantable electronic device infections and their management. Circulation. 2010; 121(3): 458–477.
  2. Blomström-Lundqvist C, Traykov V, Erba PA, et al. European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID), and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2020; 41(21): 2012–2032.
  3. Da Costa A, Lelièvre H, Kirkorian G, et al. Role of the preaxillary flora in pacemaker infections: a prospective study. Circulation. 1998; 97(18): 1791–1795.
  4. de Oliveira JC, Martinelli M, Nishioka SA, et al. Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defibrillators: results of a large, prospective, randomized, double-blinded, placebo-controlled trial. Circ Arrhythm Electrophysiol. 2009; 2(1): 29–34.
  5. Connolly S, Philippon F, Longtin Y, et al. Randomized cluster crossover trials for reliable, efficient, comparative effectiveness testing: design of the prevention of arrhythmia device infection trial (PADIT). Can J Cardiol. 2013; 29(6): 652–658.
  6. Tarakji KG, Wilkoff BL, Lieberman RA, et al. Antibacterial envelope to prevent cardiac implantable device infection. N Engl J Med. 2019; 381(18): 1782–1783.
  7. Knaepler H. Local application of gentamicin-containing collagen implant in the prophylaxis and treatment of surgical site infection in orthopaedic surgery. Int J Surg. 2012; 10 Suppl 1: S15–S20.
  8. Kaczmarek K, Strzelecki A, Ptaszyński P, et al. The safety, efficacy and cost-effectiveness of gentamycin-collagen sponge in multi-component prevention strategy of cardiac implantable electronic device infections - the single-center experience. Kardiol Pol. 2021 [Epub ahead of print].
  9. Mittal S, Wilkoff BL, Kennergren C, et al. The World-wide Randomized Antibiotic Envelope Infection Prevention (WRAP-IT) trial: Long-term follow-up. Heart Rhythm. 2020; 17(7): 1115–1122.
  10. El-Chami MF, Jacobsen CM, Griffiths RI, et al. Device-related infection in de novo transvenous implantable cardioverter-defibrillator Medicare patients. Heart Rhythm. 2021; 18(8): 1301–1309.
  11. El-Chami MF, Bonner M, Holbrook R, et al. Leadless pacemakers reduce risk of device-related infection: Review of the potential mechanisms. Heart Rhythm. 2020; 17(8): 1393–1397.
  12. Boersma L, Barr C, Knops R, et al. Implant and midterm outcomes of the subcutaneous implantable cardioverter-defibrillator registry: the EFFORTLESS study. J Am Coll Cardiol. 2017; 70(7): 830–841.
  13. Sohail MR, Corey GR, Wilkoff BL, et al. Clinical presentation, timing, and microbiology of CIED infections: an analysis of the WRAP-IT trial. JACC Clin Electrophysiol. 2021; 7(1): 50–61.
  14. Xiang K, Catanzaro JN, Elayi C, et al. Antibiotic-eluting envelopes to prevent cardiac-implantable electronic device infection: past, present, and future. Cureus. 2021; 13(2): e13088.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Sp. z o.o. VM Group Sp.k., ul. Świętokrzyska 73 , 80–180 Gdańsk, Poland

phone:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl